Development and Validation of a Novel Functional Eye-Tracking Software Application for Neurological Disorders
NCT: NCT05212727 · TERMINATED
Brief Summary
This study aims to develop and validate a sensitive and non-invasive eye-tracking software application. This study will obtain participant responses to brief cognitive tests designed to evaluate several key functions known to be affected by neurological disorders and non-invasive eye movement measurements in response to visually presented stimuli during specifically designed eye-tracking tests. The study data will be used to develop machine learning algorithms and validate a software application intended to track the progressive component of neurological disorders and associated cognitive changes.
Frequently Asked Questions
What is Development and Validation of a Novel Functional Eye-Tracking Software Application for Neurological Disorders?
Development and Validation of a Novel Functional Eye-Tracking Software Application for Neurological Disorders is a clinical trial registered under NCT05212727. Current status: TERMINATED.
What is the status of NCT05212727?
The current status of NCT05212727 (Development and Validation of a Novel Functional Eye-Tracking Software Application for Neurological Disorders) is: TERMINATED.
When did Development and Validation of a Novel Functional Eye-Tracking Software Application for Neurological Disorders start?
Development and Validation of a Novel Functional Eye-Tracking Software Application for Neurological Disorders started on 2022-04-15.
Official Source
View on ClinicalTrials.gov →Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.